HETEROCYCLES, Vol. 83, No. 2, 2011
329
was heated at 82 °C for 24 h, concentrated and the residue was recrystallized from CH2Cl2/MeOH. 0.703
g (61%), colorless crystals, mp 282-283 °C. 1H NMR (400 MHz; DMSO-d6): 13.36 (br.s, 1H, COOH),
7.15 (d, J = 8.6, 2H, Ar), 7.04-7.02 (m, 2H, Ar), 7.01-6.94 (m, 4H, Ar), 5.42 (s, 1H, H5), 4.27-4.16 (m,
2H, CH2Ar), 3.76 (s, 1H, H4), 3.67 (s, 1H, H3a), 2.99 (ddd, J = 16.4, 11.2, 9.2, 1H, H8), 2.58 (dd, J = 12.8,
9.2, 1H, H8), 2.45-2.39 (m, 1H, H9), 2.30 (dd, J = 12.8, 11.2, 1H, H9). 13C NMR (100 MHz; DMSO-d6):
178.06, 177.69, 175.66, 173.24, 161.94 (J 243.7), 137.34, 132.90, 131.23, 130.72, 130.64, 128.94 (2C),
127.04 (2C), 115.68, 115.47, 73.10, 61.57, 53.93, 52.41, 41.88, 32.89, 29.73. Anal. Calcd for
C23H18ClFN2O5: С, 60.47; Н, 3.97; N, 6.13. Found: С, 60.69; Н, 4.05; N, 6.01.
Crystal structure determination of compound 7.
The single crystal of 7 of approximate dimensions 0.40 x 0.20 x 0.20 mm was mounted in inert oil on the
top of glass fibre and transferred on the Bruker SMART APEX II diffractometer. Crystal data:
C23H18ClFN2O5, M = 456.84, monoclinic, a = 13.6113(18), b = 12.5729(18), c = 12.4174(16) Å, β =
108.234(4)°, V = 2018.3(5) Å3, space group P21/c, Z = 4, Dc = 1.503 g/cm3, F(000) = 944, µ(Mo-K) =
0.239 mm-1. Total of 18287 reflections (4187 unique, Rint = 0.0457) were measured using graphite
monochromatized Mo-K radiation (λ = 0.71073 Å) at 100 K. Data were collected in the range 1.58 < θ
< 26.54 (-17 ≤ h ≤ 17, -15 ≤ k ≤ 15, -15 ≤ 1 ≤ 15). The structure was solved by direct methods17 and
refined by full matrix least-squares on F2. All H atoms (except HO2) were placed in calculated positions
and refined using a riding model. The final residuals were: R1 = 0.0527, wR2 = 0.0981 for 3076
reflections with I > 2σ(I) and 0.0784, 0.1079 for all data and 289 parameters. Goof = 1.108, maximum Δρ
= 0.487 e/Å3.
ACKNOWLEDGEMENTS
This research was kindly supported by Russian Foundation for Basic Research (grants 08-04-01800-a and
09-03-92011-HHC_a) to K.V.K. Ms. Alexandra O. Borissova is acknowledged for X-ray investigation of
compound 7.
REFERENCES AND NOTES
1. M. Ihara, Chem. Pharm. Bull., 2006, 54, 765.
2. M. D. Burke and S. L. Schreiber, Angew. Chem. Int. Ed., 2004, 43, 46.
3. R. Messer, C. A. Fuhrer, and R. Haner, Curr. Opin. Chem. Biol., 2005, 9, 259.
4. A. K. Lawrence and K. Gademann, Synthesis, 2008, 331.
5. G. Mehta and A. Srikrishna, Chem. Rev., 1997, 97, 671.
6. M. A. Marx, A.-L. Grillot, C. T. Louer, K. A. Beaver, and P. A. Bartlett, J. Am. Chem. Soc., 1997,
119, 6153.